catechin has been researched along with Leukemia in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (5.56) | 18.2507 |
2000's | 10 (55.56) | 29.6817 |
2010's | 7 (38.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adfa, M; Efdi, M; Hayashi, M; Kakumu, A; Koketsu, M; Ninomiya, M; Tanaka, K | 1 |
Ahmadi, N; Mohamed, S; Rosli, R; Sulaiman Rahman, H | 1 |
Felix, CA; Grimwade, D; Lindsey, RH; Osheroff, N; Pendleton, M | 1 |
Chen, W; Chen, Z; Lv, M; Ma, T; Yu, X; Zhao, J; Zhong, S | 1 |
Huang, Y; Kay, NE; Kumazoe, M; Lesnick, C; Shanafelt, TD; Tachibana, H; Tsukamoto, S | 1 |
Bode, AM; Chae, JI; Choi, BY; Choi, HS; Dong, Z; Lee, SY; Pugliese, A; Shim, JH | 1 |
Chan, TH; Davenport, A; Dou, QP; Frezza, M; Ge, Y; Huo, C; Shen, M | 1 |
Baran, I; Barresi, V; Cirrone, GA; Condorelli, DF; Cuttone, G; Ganea, C; Garaiman, A; Grasso, R; Gulino, M; Mocanu, MM; Musso, N; Musumeci, F; Privitera, S; Scordino, A; Ursu, I | 1 |
Bachrach, U; Wang, YC | 1 |
Asakage, M; Hori, N; Kawai, K; Kitayama, J; Nagawa, H; Okaji, Y; Takahashi, K; Tsuno, NH; Watanabe, T; Yazawa, K | 1 |
Cao, J; Li, Y; Liu, JW; Qu, HY; Ren, LL | 1 |
Baatout, S; Derradji, H; Jacquet, P; Mergeay, M | 1 |
Kizaki, M | 1 |
de Haan, G; Rizo, A; Schuringa, JJ; Vellenga, E | 1 |
Kaul, D; Mehrotra, A | 1 |
Chan, TH; Dou, QP; Landis-Piwowar, KR; Osanai, K | 1 |
Asano, Y; Eto, T; Niho, Y; Ogo, T; Otsuka, T; Suganuma, M | 1 |
Dou, QP; Smith, DM | 1 |
3 review(s) available for catechin and Leukemia
Article | Year |
---|---|
Topoisomerase II and leukemia.
Topics: Animals; Antineoplastic Agents; Catechin; Cell Transformation, Neoplastic; Chromosome Breakage; Curcumin; DNA Topoisomerases, Type II; Genistein; Humans; Infant; Leukemia; Neoplasms, Second Primary; Translocation, Genetic | 2014 |
Tea consumption and leukemia risk: a meta-analysis.
Topics: Catechin; Humans; Leukemia; Publication Bias; Risk; Tea | 2014 |
Signaling pathways in self-renewing hematopoietic and leukemic stem cells: do all stem cells need a niche?
Topics: Animals; Catechin; Cell Differentiation; Cell Transformation, Neoplastic; Cytokines; Epigenesis, Genetic; Glycosides; Growth Substances; Hematopoietic Stem Cells; Humans; Leukemia; Mice; Models, Biological; Neoplastic Stem Cells; Pluripotent Stem Cells; Signal Transduction | 2006 |
15 other study(ies) available for catechin and Leukemia
Article | Year |
---|---|
Phytochemical analysis and antileukemic activity of polyphenolic constituents of Toona sinensis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HL-60 Cells; Humans; Leukemia; Meliaceae; Molecular Conformation; Phytochemicals; Phytotherapy; Plant Extracts; Plant Leaves; Structure-Activity Relationship; Wood | 2014 |
Epicatechin and scopoletin-rich Morinda citrifolia leaf ameliorated leukemia via anti-inflammatory, anti-angiogenesis, and apoptosis pathways in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Apoptosis; Catechin; Drugs, Chinese Herbal; Humans; Interleukin-10; Interleukin-4; Leukemia; Male; Mice; Mice, Inbred BALB C; Morinda; Scopoletin | 2019 |
SphK1 inhibitor potentiates the anti-cancer effect of EGCG on leukaemia cells.
Topics: Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Survival; Drug Synergism; Enzyme Inhibitors; Gene Expression; Humans; Leukemia; Phosphotransferases (Alcohol Group Acceptor) | 2017 |
(-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase.
Topics: Apoptosis; Catechin; CD3 Complex; Cell Line, Tumor; Gene Expression Regulation, Leukemic; Humans; Interleukin-2; Jurkat Cells; Leukemia; Models, Biological; Molecular Conformation; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocytes; ZAP-70 Protein-Tyrosine Kinase | 2008 |
Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cytarabine; Daunorubicin; Fusion Proteins, bcr-abl; Humans; Leukemia; Molecular Structure; Pentacyclic Triterpenes; Plant Extracts; Prodrugs; Triterpenes | 2010 |
Detailed analysis of apoptosis and delayed luminescence of human leukemia Jurkat T cells after proton irradiation and treatments with oxidant agents and flavonoids.
Topics: Apoptosis; Catechin; Cell Cycle; Cell Survival; Clone Cells; Flavonoids; Humans; Hydrogen Peroxide; Jurkat Cells; Kinetics; Leukemia; Luminescence; NADP; Oxidants; Protons; Quantum Theory; Quercetin; Time Factors; Vitamin K 3 | 2012 |
The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Blotting, Western; Catechin; Cell Division; Cell Line, Transformed; Cell Transformation, Neoplastic; Cyclophosphamide; Drug Screening Assays, Antitumor; Genes, ras; Humans; Leukemia; Mice; Mitogen-Activated Protein Kinases; Ornithine Decarboxylase; Phosphorylation; Tea; Tumor Cells, Cultured | 2002 |
Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding.
Topics: Antibodies, Monoclonal; Antiviral Agents; Catechin; CD4 Antigens; Cells, Cultured; Endocytosis; Flavonoids; HIV Envelope Protein gp120; Humans; Leukemia; Phenols; Polyphenols; T-Lymphocytes; Tea | 2003 |
Gene expression spectra in human leukemia HL-60 cells treated with EGCG.
Topics: Base Sequence; Catechin; DNA Primers; Gene Expression Profiling; HL-60 Cells; Humans; Leukemia; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Increased radiation sensitivity of an eosinophilic cell line following treatment with epigallocatechin-gallate, resveratrol and curcuma.
Topics: Annexin A5; Apoptosis; Catechin; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Curcuma; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Eosinophils; Flow Cytometry; Humans; Leukemia; Necrosis; Plant Extracts; Radiation Tolerance; Radiation, Ionizing; Resveratrol; Signal Transduction; Stilbenes; Time Factors; X-Rays | 2005 |
[Establishment of a novel molecular-targeted therapy for hematological malignancies mediated through reactive oxygen species (ROS)].
Topics: Antineoplastic Agents; Apoptosis; Capsaicin; Catechin; Homeostasis; Humans; Leukemia; Mitochondria; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species | 2006 |
Functional characterization of AATF transcriptome in human leukemic cells.
Topics: Androstadienes; Apoptosis; Apoptosis Regulatory Proteins; Base Sequence; Catechin; Cell Survival; Flow Cytometry; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Jurkat Cells; Leukemia; Models, Biological; Molecular Sequence Data; Proto-Oncogene Proteins c-myc; Repressor Proteins; Response Elements; Sp1 Transcription Factor; Transcription Factors; Transcription, Genetic; Wortmannin | 2007 |
A para-amino substituent on the D-ring of green tea polyphenol epigallocatechin-3-gallate as a novel proteasome inhibitor and cancer cell apoptosis inducer.
Topics: Apoptosis; B-Lymphocytes; Caspase 3; Catechin; Cell Line, Tumor; Humans; Leukemia; Molecular Structure; Proteasome Endopeptidase Complex; Structure-Activity Relationship; Tea | 2007 |
Growth inhibition of leukemic cells by (-)-epigallocatechin gallate, the main constituent of green tea.
Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Division; Cell Lineage; Cell Survival; Cells, Cultured; DNA; DNA Fragmentation; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-3; Leukemia; Mice; Tea; Tumor Cells, Cultured | 1998 |
Green tea polyphenol epigallocatechin inhibits DNA replication and consequently induces leukemia cell apoptosis.
Topics: Apoptosis; Catechin; Cell Cycle; Cell Division; DNA; Dose-Response Relationship, Drug; Flavonoids; Flow Cytometry; HL-60 Cells; Humans; In Situ Nick-End Labeling; Jurkat Cells; K562 Cells; Leukemia; Models, Chemical; Phenols; Plant Extracts; Polymers; Tea; Thymidine; Time Factors | 2001 |